New approach methodologies

New approach methodologies (NAMs) are alternative testing protocols, technologies, and strategies that are in alignment with the 3Rs principles (Replacement, Reduction and Refinement) for the ethical use of animal models.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

New approach methodologies (NAMs) are alternative testing protocols, technologies, and strategies that are in alignment with the 3Rs principles (Replacement, Reduction and Refinement) for the ethical use of animal models. Both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA), the two principal authorities in global pharmaceutical regulation, have established frameworks to facilitate the evaluation and potential integration of these NAMs into regulatory pipelines.

NAMs comprise basic 2D cell-based assays, advanced 3D in vitro human-derived systems such as organoids or organs-on-a-chip, predictive in silico computational models such as QSAR and omics such as transcriptomics technologies among other techniques. By using these human-derived biological models, NAMs are designed to predict human health outcomes, lower operational costs, and accelerate drug development schedules.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1372420547 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

10 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.